We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spire Healthcare Group Plc | LSE:SPI | London | Ordinary Share | GB00BNLPYF73 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.00 | 0.43% | 233.00 | 232.50 | 233.50 | 233.00 | 231.50 | 231.50 | 24,671 | 11:06:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 1.36B | 27.3M | 0.0676 | 34.39 | 939.6M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/9/2015 09:23 | Interesting but who would run a big group of hospitals>>> That is the big block to these deals and that is why SPI is run not by doctors but professional managers of businesses. Nevertheless the UK needs to support the NHS and private hospital groups especially as we all get older and its this segment who now has the disposal income to keep fit and well.........just go down to the Spire in Cambridge and see what I see most days and also look at where some of the patients come from.....Addenbrooke | anley2 | |
29/9/2015 08:44 | CapVest to sell stake in Mater Investment firm CapVest is looking to exit its majority investment in Mater Private Healthcare early next year. The Sunday Times has reported that CapVest is in the process of selecting a firm to run the sale process with Investec and Rothschild believed to be in the frame. The move follows the collapse of a potential sale of Mater to South African hospital operator Netcare. It was reported that Netcare’s unsolicited offer valued Mater at €500 million (£367.8 million). Furthermore, last year Capvest proposed a merger between Mater and Hermitage, another Irish private hospital but the talks fell through, as well. There has been speculation that Netcare, Spire Healthcare and Mater’s management team will be potential bidders for the Irish hospital group. CapVest acquired a 51% stake in the Mater Private Hospital Dublin in 2007, a deal which valued the hospital at €350 million. The private hospital group then bought Cork Medical Centre for €90 million in 2011. In addition to the two hospitals, Mater now also operates two cancer centres in Limerick and Liverpool (as part of a joint venture with Clatterbridge Cancer Centre NHS Trust) and outpatient clinics in Drogheda, Navan and Sligo. The company provides healthcare for members of the Dubai Police Force and their families too. Mater has annual revenues of €200 million | igoe104 | |
14/9/2015 09:30 | Woodford and his gang have topped up to with the new SA shareholder they control over 40% of the business and are in there long term. | anley2 | |
25/8/2015 06:53 | Where Next For Spire Healthcare Group PLC After Today’s Results? By Motley Fool | Fri, 21st August 2015 - 11:23 Share this Hospital group Spire Healthcare Group (LSE:SPI) has led the FTSE laggards in end-of-week business and was last dealing 12.9% lower from Thursday's close. Today's weakness puts to an end the recent bull run that has seen the stock advance almost a quarter since the end of June, an advance that saw the firm print record peaks of 401.6p per share just yesterday. So what's going on? Spire's insipid performance today has been prompted by half-year results that missed forecasts. The health specialists saw underlying revenues advance 5% during January-June, to £449.8m, a result that helped Spire swing to a pre-tax profit of £39.4m from a loss of £1.7m a year earlier. Added to this, Spire spooked investors by announcing that "because of recent actions taken in response to the NHS Trusts' estimate of aggregate deficits for 2015/16, we recognise that there may be some near-term weakness in NHS demand over the remainder of this financial year." And these problems have already begun to seep into activity at Spire by the looks of things. Total NHS sales advanced 14.1% during the first half, a performance that Investec describes as disappointing -- the broker noted that "we expected strong volumes as waiting lists were cleared ahead of the election, but these do not appear to have materialised." Spire now expects demand from NHS customers to flatline in the second half of the year, forcing the business to downgrade its full-year revenues and earnings growth forecasts to between 4% and 6%. Previously Spire said that it expected to enjoy "mid to single digit" expansion in 2015. So what next? Still, Spire remains bullish over the potential of its its NHS division and commented that "the medium-to-long term trends in this business remain very positive," adding that demand from PMI and self-pay customers continues to surge higher. Indeed, the result of financial constraints on NHS waiting lists at present time could push the number of private patients coming through Spire's doors, the company noted. Naturally today's announcement is likely to lead to hefty earnings downgrades across the City. But for many today's hefty fall could represent a fresh buying opportunity -- the company's expansion scheme remains on track and new hospitals in Manchester and Nottingham are due to open during the first quarter of 2017. On top of this, Medicare's purchase of a 29.9% stake back in June should boost its potential in overseas markets, not to mention turbocharge cost reduction across the business. In my opinion Spire's long-term growth case remains a compelling one. | igoe104 | |
25/8/2015 06:51 | After the big fall, and looking closely at the current situation, I decided to get back in yesterday at just over £2.22. if Medicare's are happy to pay £3.60 there had to be value at these levels. | igoe104 | |
21/8/2015 16:12 | NHS budget cuts hit private medical provider Spire Healthcare Shares in the independent hospitals group plummet as cost-cutting in the NHS weighs on second-half performance. | igoe104 | |
21/8/2015 14:08 | Bad day for a few words of caution and looks very overdone. | its the oxman | |
21/8/2015 07:43 | Abcd....yes interesting about Berenberg! Sticking with it long term. Apart from the Nhs announcement appears fine to me. Could drift of course especially with current market uncertainties. | gswredland | |
21/8/2015 07:39 | Profit warning - but for the NHS business which is 29% of the total. Remainder reads positive to me. | trader2 | |
21/8/2015 07:36 | ~~~~~~~~~~~~~~~~~~~~ 17/8/15 IN THE KNOW: Berenberg Expects "Reassuring" Interim Results From Spire ~~~~~~~~~~~~~~~~~~~~ .... a lesson for p.i.'s there, re analysts etc | abcd1234 | |
21/8/2015 07:28 | Profit warning, didn`t see this coming, sold out for a 2k profit. I can only see this drifting back down to £3 over the next month, very disappointing. Because of recent actions taken in response to the NHS Trusts' estimate of aggregate deficits for 2015/16, we recognise that there may be some near-term weakness in NHS demand over the remainder of this financial year | igoe104 | |
20/8/2015 12:14 | Cinven have sold up, whats the worry. £4 BROKEN now, this should be a good solid/ safe investment over the coming years. Glad I got back in a £3.24 | igoe104 | |
13/8/2015 17:08 | The more I look at this chart the more 'curious' I find the accelerated share value just before each Cinven sale....am I the only one? | c4rver | |
13/8/2015 16:25 | Yep keeps trying! | gswredland | |
10/8/2015 12:42 | Breakout on the cards | jamdan1 | |
06/8/2015 14:59 | Meena9, they are UT trades uncrossed trades at Auction price. | johnv | |
06/8/2015 06:33 | I have noticed every day a chunky trade just after 16.30. buys or sells?? | meena9 | |
31/7/2015 13:17 | Im in the same camp as you...as soon as I buy in or sell it goes against me. Nice to be in a share that seema to want to go up for a change....hope i ve mot spoken to soon. | jamdan1 | |
31/7/2015 12:58 | Coz I traded out yesterday for a 10pc gain Jamden, may buy back in if it breaks out of a 52 week range . | fruitninja84 | |
31/7/2015 12:26 | Anyone have an idea why its doing so well today? | jamdan1 | |
24/7/2015 07:29 | Berenberg Starts Spire Healthcare Group (LON:SPI) Coverage With “Buy” Rating and GBX 420.00 | igoe104 | |
20/7/2015 19:33 | Chart looks poised for a move through 400p. | its the oxman | |
02/7/2015 07:25 | Creeping up nicely now, this should turn into a nice solid investment over the coming years. | igoe104 | |
30/6/2015 12:31 | I`ve decided to buy back in today. good to see the fund buy VC stake for £3.60. | igoe104 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions